SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is driving intense retail and institutional engagement as market participants debate the massive valuation gap between current fundamentals and its long-term potential in space exploration and AI. The community is actively tracking the upcoming launch of options trading and the potential for a gamma squeeze, while investors remain split between riding the extreme momentum and cautioning against a bubble-like IPO performance.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing significant momentum as analysts aggressively raise price targets, citing long-term HBM supply shortages and a structural shift in memory demand driven by AI infrastructure. While the community remains highly bullish and focused on potential post-earnings momentum, some participants are closely watching macroeconomic volatility and geopolitical headlines for signs of market rotation.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently a major focus for investors due to its role in the quantum sensing and navigation sectors, with significant community speculation centered on a potential partnership with SpaceX to bolster satellite resilience in GPS-denied environments. The stock is generating intense discussion as traders weigh its existing government contracts, NASA hardware deployments, and NVIDIA ecosystem integration against ongoing volatility and concerns surrounding recent insider share sales.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is seeing significant community discussion as investors monitor potential China market divestment strategies and anticipation builds for the upcoming annual earnings, which many hope will solidify the company's turnaround narrative. Sentiment remains split between frustration over stagnant price action and conviction in the brand's long-term growth as new product rollouts and expanded distribution in the US and Europe continue to gain traction.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing downward pressure amid investor concerns over heavy capital expenditure related to AI data center expansion, while community sentiment remains divided between those viewing the pullback as a buying opportunity in a fundamental powerhouse and those frustrated by the stock's lack of momentum compared to other mega-caps. Market participants are also actively debating the broader implications of rising AI infrastructure costs and the competitive impact of Amazon's expanding logistics and supply chain services.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending as investors aggressively debate the sustainability of its massive, multi-bagger rally, with the community split between those betting on continued momentum driven by AI memory demand and skeptics calling for a potential pullback due to overextended technical indicators. The conversation centers on whether the current valuation is a fundamental re-rating based on long-term supply contracts or a speculative bubble reminiscent of past market excesses.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors monitor the imminent closing of the Northern Data acquisition, a move widely viewed by the community as a major pivot into AI and cloud infrastructure that could significantly expand its GPU capacity. Market sentiment is heavily focused on the stock's high short interest and potential for a squeeze, with supporters pointing to institutional ties and upcoming management presentations as key catalysts for a valuation re-rate.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render is currently a focal point for the community due to its leadership in the DePIN and decentralized AI compute narratives, with investors debating its long-term potential as a critical infrastructure play for the AI economy. Despite recent price volatility and investor frustration regarding chart performance, many see the current levels as a strategic accumulation opportunity driven by growing real-world utility and GPU demand.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending as investors react to the company's Q1 2026 earnings, which featured a significant leadership transition with the departure of its co-founders and weaker-than-expected revenue guidance. Despite these near-term headwinds and ongoing debate regarding the company's oncology pipeline efficacy, the community remains divided, with bulls highlighting its massive cash position and potential for oncology market disruption, while bears express concern over the company's pivot strategy and operational losses.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

Investors are actively debating the sustainability of the current market rally as ongoing geopolitical tensions and extreme technical indicators fuel speculation about a potential correction. The community remains divided, with many traders utilizing leveraged inverse ETFs to hedge against perceived bubble risks while others argue that institutional momentum and AI sentiment continue to drive upward pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begins Priority Review of the NDA with a Sept. 26, 2026, decision date.

MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review

AstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indication

AZN wins FDA approval to expand Truqap's use in PTEN-deficient prostate cancer, backed by phase III data showing improved outcomes and broader use.

INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026

Long-acting injectable adoption remains low, but Indivior's market position, payer access and consumer campaign could help drive growth into 2026.

Is Indivior Stock a Buy After Higher 2026 Guidance?

Indivior raised 2026 guidance after strong Q1 results, but investors are watching whether Sublocade growth and margin gains can sustain momentum.

INDV Stock: What Sublocade Growth Signals for 2026

Sublocade is powering Indivior's growth with record patient starts, rising volumes and a stable market share, setting up key demand tests for 2026.

Immunovant Stock Gains 12.4% in a Month: What's Driving It?

IMVT shares climb as IMVT-1402 posts encouraging data, advances across autoimmune diseases and benefits from a cash runway extending through launch.

GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder

GSK's momelotinib wins FDA and EMA orphan status for VEXAS syndrome, backed by early evidence. The company advances a phase II/III study.

IMRX Begins Dosing in Phase III Pancreatic Cancer Study, Stock Up

Immuneering stock rises after dosing the first patient in a pivotal phase III study of atebimetinib plus mGnP for first-line metastatic pancreatic cancer.

Novo Nordisk Stock Up as UK Wegovy Pill Nod Eclipses Security Breach

NVO stock gains 3% as the United Kingdom becomes Europe's first country to approve the daily GLP-1 Wegovy weight-loss pill, overshadowing an IT security breach.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.79	--	--	N/A
Q1 '26	$0.41	$0.52	26.78%	BEAT
Q4 '25	$0.24	$0.15	-36.33%	MISSED
Q3 '25	-$0.39	-$0.04	89.73%	BEAT
Q2 '25	-$0.42	-$0.49	-16.36%	MISSED

LQDALiquidia Corp

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest LQDA News